[![GPLv3 license](https://img.shields.io/badge/License-GPLv3-blue.svg)](http://perso.crans.org/besson/LICENSE.html)

# Post PCI

Risk calculation for patients that continue thienopyridine treatment beyond one year after percutaneous coronary intervention (PCI) based on DAPT study
